Search

everythinglearnresearchcommunity

for

Search:↓

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Histone modification is key in treating chronic inflammatory skin diseases.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Early diagnosis and treatment of nail and skin conditions can improve health and appearance.

Men with a certain type of hair loss often use facial moisturizers, and a specific antibiotic treatment may help another hair condition.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

A 5-year-old boy with alopecia totalis had temporary hair regrowth with treatment but relapsed, highlighting the need for thorough investigation and holistic care.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.

Combining CGF and microneedling with betamethasone effectively treats resistant alopecia areata.

The study found that alopecia areata is strongly linked to autoimmune diseases and may indicate a genetic predisposition to such conditions.

Scalp melanoma, a deadly skin cancer, is often found late due to its hard-to-see location, especially in older men. Early detection, possible treatments, and the role of hairdressers in spotting it early are discussed. More research is needed to improve detection and treatment.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Trichloroethylene causes skin inflammation in mice by increasing certain immune proteins.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

The nail matrix has a reduced immune response, protecting it from autoimmunity.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

TNF-alpha inhibitors can cause various immune-related skin issues.

Tamarix aphylla may be effective for various medical conditions, but more research is needed to confirm its safety and effectiveness.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Topical tofacitinib is effective and safe for treating alopecia areata.

Human dermal γδT-cells respond to stress in hair follicles, contributing to hair loss.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.